Cracking Complex Generics: The Bioequivalence Playbook That Gets ANDAs Approved
Generic competition is no longer just about filing a paragraph IV. It’s about proving your product behaves like the reference—down to the biology.
That’s the real story behind the “bioequivalence playbook” for ANDA approvals—and why the companies tha…
Cracking Complex Generics: The Bioequivalence Playbook That Gets ANDAs Approved Read Post »
